| 1. *Retinal Dystrophies/ |
| 2. *Retinitis Pigmentosa/ |
| 3. (Pigmentary retinopathy or Rod-cone dystroph* or Rod cone dystroph* or Retinal Dystroph* or Retinitis
pigmentosa or pigmentary retinosis or retinosis pigmentary or retinosis pigmentosa or North Carolina Macular Distrophy or Stargardt-Fundus flavimaculatus or stargardt's fundus flavimaculatus or Stargardt's disease or Stargardt Macular Degeneration or Stargardt disease or fundus flavimaculatus or Sorsby dystrophy or Gyrate Atrophy or Atrophia Gyrata or Enhanced S-cone Syndrome or Goldman-Favre or Wagner-Stickler or vitreoretinal dystroph* or X-linked Juvenile retinoschisis or Occult Macular Dystrophy or Macular dystroph* or Choroideremia or Congenital Stationary Night Blindness or central areolar choroidal dystrophy or Bestrophinopathy or Bestrophinopathies or Best Vitelliform Macular Dystrophy or Vitelliform Macular Dystrophy or Familial Exudative vitreoretinopathy or adult-onset foveomacular Dystrophy or Butterfly-shaped pattern dystrophy or Pattern dystrophies in Retinal Pigment Epithelium or Autosomal dominant Stargardt-like macular dystrophy or Stargardt Macular Degeneration or Stargardt disease or hereditary retinal dystroph* or inherited retinal dystroph*).ab,ti. |
| 4. 1 or 2 or 3 |
| 5. *Drug Therapy/ or *Therapeutics/ or *Disease Management/ or *Vitamins/ |
| 6. (therap* or drug therapy or intervention or interventions or treatment or treatments or disease management or Vitamin or Supplementation).ab,ti. |
| 7. (Therapeutic adj2 (aspects or interventions or procedure)).ab,ti. |
| 8. 5 or 6 or 7 |
| 9. *Treatment Outcome/ |
| 10. (Effectiveness or Efficacy or Security or Adverse effect or Adverse effects or Adverse event or Adverse events or Adverse reaction or Adverse reactions or Side effect).ab,ti. |
| 11. 9 or 10 |
| 12. 4 and 8 and 11 |
| 13. limit 12 to humans |
| 14. limit 13 to (english or Spanish) |
| 15. remove duplicates from 14 |
